NCT04631393View on ClinicalTrials.gov

Patient-controlled Sedation in Port Implantation (PACSPI-1)

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

October 15, 2021

Study Completion Date

October 15, 2021

Conditions
PainPatient Satisfaction
Interventions
DRUG

Propofol Alfentanil

Propofol and Alfentanil are self-administered by the participant.

Trial Locations (1)

55185

Länssjukhuset Ryhov, Jönköping

All Listed Sponsors
lead

Stefanie Seifert

OTHER_GOV